Aridis Pharmaceuticals announced first Investor call of 2022 for today, after the closing bell.
Exiting pipeline with 2 phase 3 drugs and their monoclonal antibody cocktail.
AstraZeneca PLC (AZN) has a stake in this company.
CEO has co-developed several drug which have been sold to Astra Zeneca, Megabits and MedImmune.
Aridis Pharmaceuticals can be a potential...
